Identification of women at high risk of developing endometrial cancer on tamoxifen

Eur J Cancer. 2000 Sep:36 Suppl 4:S35-6. doi: 10.1016/s0959-8049(00)00217-3.

Authors

M Berlière¹, G Radikov, C Galant, P Piette, E Marbaix, J Donnez

Affiliation

¹ Department of Gynaecology, Catholic University of Louvain, Ave. Hippocrate, 10 - B-1200, Brussels, Belgium.

PMID: 11056310
DOI: 10.1016/s0959-8049(00)00217-3

No abstract available

MeSH terms

Antineoplastic Agents, Hormonal / adverse effects*
Breast Neoplasms / drug therapy
Endometrial Neoplasms / chemically induced*
Female
Humans
Patient Selection
Polyps / chemically induced
Risk Factors
Tamoxifen / adverse effects*

Substances

Antineoplastic Agents, Hormonal
Tamoxifen